UNSPSC 85891829: High dose rate (hdr) brachytherapy of pituitary gland using iridium 192 (ir-192)

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of high dose rate (hdr) brachytherapy of pituitary gland using iridium 192 (ir-192). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code DG1098Z

UNSPSC 85891829 High dose rate brachytherapy of pituitary gland using iridium 192 (Ir-192) is a Commodity code that shows a significant mismatch between its nominal scope — a specialized radiation oncology procedure — and the state and local procurement activity currently tagged to it. The recent opportunity on record, a County of Santa Clara Health System RFQ posted July 7, 2026, solicits temporary health professional staffing services across ancillary clinical categories including audiology, cardiology, diagnostic imaging, gastroenterology, medical social work, ophthalmology, orthopedic services, respiratory care, sterile processing, surgical and operating room support, and therapy services. This staffing solicitation bears no relationship to brachytherapy treatment and appears to reflect a classification error at the time of posting rather than representative procurement under the code.

No recent state and local opportunities directly soliciting high-dose-rate brachytherapy equipment, supplies, treatment planning, or related oncology services appear in the available record. The single tagged opportunity — a non-exclusive, multiple-award qualification vehicle for temporary clinical staffing with a response date of October 7, 2026 — does not reflect procurement activity aligned with the code's stated scope. Business development professionals should verify whether this code actually receives state and local solicitations for brachytherapy-related products or services before pursuing it as an active market category.